Tranexamic Acid Dosing for Fibroid-Related Bleeding

Recommended Dosing Regimens

• The European guideline for management of bleeding recommends tranexamic acid 10-15 mg/kg followed by an infusion of 1-5 mg/kg per hour for fibrinolysis management 1, 2

Mechanism of Action and Pharmacokinetics

• Tranexamic acid is a synthetic lysine analogue that competitively inhibits plasmin and plasminogen, preventing fibrin degradation 1, 2
• The plasma half-life is approximately 120 minutes, requiring multiple daily doses or continuous infusion to maintain therapeutic levels 1, 2
• In vitro studies suggest that a plasma concentration of 10 μg/ml is required to inhibit fibrinolysis 1, 2

Efficacy in Fibroid-Related Bleeding

• Tranexamic acid is a nonhormonal alternative agent that can reduce bleeding symptoms in patients with fibroids 3

Safety Considerations

• Tranexamic acid should be used with caution in patients taking oral contraceptives due to increased thrombotic risk 4
• Dose adjustment is required in patients with renal dysfunction based on serum creatinine levels 4

Clinical Considerations

• Antifibrinolytic therapy should be guided by thrombelastometric monitoring if possible and stopped once bleeding has been adequately controlled 1, 2
• Tranexamic acid should be discontinued 5 days before high bleeding risk procedures or surgery in confined spaces 4